LPL Financial (LPLA) opened its new San Diego headquarters, Tower II at La Jolla Commons, on Wednesday. The independent broker-dealer — which also has headquarters in Boston and Charlotte, N.C. — says the structure is one of the largest net-zero energy commercial office buildings in the United States.
About 1,600 LPL Financial employees, who previously worked in seven office buildings in the La Jolla area of San Diego, are now based in the new 13-story facility.
"At LPL Financial, we are ambitiously working to be an employer of choice. As part of this commitment, we knew that our work environment needed to make an investment both in our employees and in the San Diego community,” said LPL Chairman and CEO Mark Casady, in a press release.
“Utilizing advances in technology to create efficiencies is at the heart of what LPL Financial provides for its advisors and institutional clients…,” Casady explained. “Leveraging technology and advanced materials to minimize our impact on the environment, while creating a positive work environment for our employees, is consistent with our values as a firm and indicative of our strong commitment to being a socially responsible corporate citizen."
Top Diversified Bank Stocks To Watch For 2015: Rofin-Sinar Technologies Inc.(RSTI)
Rofin-Sinar Technologies Inc., together with its subsidiaries, engages in the design, development, engineering, manufacturing, and marketing of laser-based products worldwide. The company offers laser macro products to machine tool and automotive markets for cutting and welding of metals. It also provides laser marking products to semiconductor and electronics markets for the marking of integrated circuits, wafers, solar cells, electronic components, and smart cards, as well as to automotive markets for the marking of labels and car components. In addition, the company offers laser micro products for fine welding, fine cutting, micro structuring, and drilling applications in medical devices, semiconductor and electronics, photovoltaic, dental, and jewelry markets; and for perforating and scribing of paper and foils in packaging and paper industries. Further, it provides components to laser industry. The company sells its products in approximately 65 countries to original e quipment manufacturers, systems integrators, and industrial end-users. Rofin-Sinar Technologies Inc. was founded in 1975 and is based in Plymouth, Michigan.
Advisors' Opinion:- [By Brian Stoffel]
Rofin-Sinar (NASDAQ: RSTI ) , Coherent (NASDAQ: COHR ) , Newport (NASDAQ: NEWP ) , and JDS Uniphase (NASDAQ: JDSU ) all offer fiber-optic lasers as well.
- [By Brian Stoffel]
For decades, the standard technology in the laser industry has been the carbon-based laser. In reality, these lasers are still commonly used, and sold in bulk by the likes of Rofin-Sinar (NASDAQ: RSTI ) and Coherent (NASDAQ: COHR ) . They are used largely for precision cutting of large pieces of metal.
Hot Tech Stocks To Buy Right Now: Cavium Networks Inc.(CAVM)
Cavium, Inc. designs, develops, and markets semiconductor processors for intelligent and secure networks. Its semiconductor products enable customers to develop networking, wireless, storage, and electronic equipment that are application-aware and content-aware, and process voice, video, and data traffic. The company?s products also include a suite of embedded security protocols, which enable unified threat management (UTM), secure connectivity, network perimeter protection, deep packet inspection, network virtualization, broadband gateways, third generation/fourth generation (3G/4G) wireless infrastructure, storage systems, wireless high-definition multimedia interface (HDMI) cable replacement, and embedded video applications. Its products are used in networking equipment, such as routers, switches, content-aware switches, UTM and other security appliances, application-aware gateways, voice/video/data gateways, wireless local area network, 3G/4G Wimax/Long Term Evolution access, aggregation and gateway devices, storage networking equipment, servers and intelligent network interface cards, Internet protocol surveillance systems, digital video recorders, wireless HDMI cable replacement systems, and video conferencing systems; and connected home and office equipment, such as print servers, wireless routers, and broadband gateways. In addition, the company offers embedded Linux operating system, related development tools, support, and professional services. It sells its products directly or through contract manufacturing organizations and distributors to the providers of networking, wireless, storage, and consumer electronic equipment; and to original design manufacturers and contract electronics manufacturers primarily in the United States, China, Taiwan, Japan, and Malaysia. The company was formerly known as Cavium Networks, Inc. and changed its name to Cavium, Inc. in June 2011. Cavium, Inc. was founded in 2000 and is headquartered in San Jo se, California.
Advisors' Opinion:- [By Ben Levisohn]
Krishna and Krauklis note that Buffalo Wild Wings, Nextera Energy (NEP), Rexnord Corp (RXN), and The Advisory Board (ABCO) should benefit from recent acquisitions that should boost revenue growth, while�Buffalo Wild Wings and Cavium (CAVM) should see improvements thanks to the adoption of new technology that will help boost margins. Terex, The Advisory Board, and�Rexnord should get a boost from cost cutting, Krishna and Krauklis say.
Hot Tech Stocks To Buy Right Now: Systemax Inc.(SYX)
Systemax Inc. operates as a direct marketer of brand name and private label products. The company operates in two segments, Technology Products and Industrial Products. The Technology Products segment sells computers, computer supplies, and consumer electronics in North America and Europe. This segment offers individual technology products in categories, including computers; computer parts; television and video; audio; cameras and surveillance; car and GPS; cell phones; software; video games and toys; home and office; and other products. The Industrial Products segment sells various industrial products and supplies in North America. This segment provides products in categories, such as material handling; storage and shelving; workbench and shop desks; packaging and supplying; furniture and office; foodservice and appliances; janitorial and maintenance; tools and instruments; fasteners and hardware; motors and power transmission; HVAC/R and fans; electrical and bulbs; plumb ing supplies; and safety and medical items. The company offers its products through its relationship marketers, catalog mailings, and Internet Websites. It serves individual consumers; and business customers comprising for-profit businesses, educational organizations, and government entities. Its portfolio of catalogs comprises various brand names, such as TigerDirect.com, Global Computer Supplies, TigerDirect.ca, Misco, Global Industrial, Nexel, and Inmac WStore. As of December 31, 2011, the company operated 42 retail stores in North America; and 7 distribution centers in Europe. Systemax Inc. was founded in 1949 and is headquartered in Port Washington, New York.
Advisors' Opinion:- [By Rich Duprey]
Loyalty and marketing specialist Alliance Data Systems (NYSE: ADS ) grabbed a tiger by the tail with a multiyear agreement to�provide private label credit card services�to�Systemax (NYSE: SYX ) subsidiary TigerDirect.
- [By Seth Jayson]
Calling all cash flows
When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on Systemax (NYSE: SYX ) , whose recent revenue and earnings are plotted below.
Hot Tech Stocks To Buy Right Now: DAQQ New Energy Corp.(DQ)
Daqo New Energy Corp., together with its subsidiaries, manufactures and sells polysilicon in China. The company sells its polysilicon to photovoltaic product manufacturers for use in the processing of ingots, wafers, cells and modules for solar power solutions. It also produces and sells mono-crystalline and multi-crystalline modules to photovoltaic system integrators and distributors in China and internationally under its Daqo brand. The company was formerly known as Mega Stand International Limited and changed its name to Daqo New Energy Corp. in August 2009. Daqo New Energy Corp. was founded in 2006 and is headquartered Wanzhou, the People?s Republic of China.
Advisors' Opinion:- [By Ali Berri]
In trading on Friday, energy shares were relative leaders, up on the day by about 0.42 percent. Meanwhile, top gainers in the sector included Daqo New Energy (NYSE: DQ), up 9.4 percent, and Goodrich Petroleum (NYSE: GDP), up 6.2 percent.
- [By Lisa Levin]
Daqo New Energy (NYSE: DQ) shares gained 12.78% to $33.58 on quarterly results.
SINA (NASDAQ: SINA) rose 7.26% to $51.29 after the company reported upbeat quarterly results.
Hot Tech Stocks To Buy Right Now: Puma Biotechnology Inc (PBYI)
Puma Biotechnology, Inc., incorporated in April 2007, is a development-stage biopharmaceutical company that acquires and develops products for the treatment of various forms of cancer. The Company focuses on in-licensing drug candidates that are undergoing or have already completed initial clinical testing for the treatment of cancer and then seeks to further develop those drug candidates for commercial use. As of December 31, 2011, the Company licensed three drug candidates: PB272 (neratinib (oral)), which the Company is developing for the treatment of advanced breasts cancer patients and gastric cancer patients; PB272 (neratinib (intravenous)), which the Company is developing for the treatment of advanced cancer patients, and PB357.
PB272 (neratinib (oral))-Breast Cancer
Neratinib is a potent irreversible tyrosine kinase inhibitor, or TKI, that blocks signal transduction through the epidermal growth factor receptors (EGFRs), HER1, HER2 and HER4. The Company's initial focus is on the development of neratinib as an oral treatment of patients with HER2 positive metastatic breast cancer.
PB272 (neratinib (intravenous))
The Company develops neratinib as an intravenously administered agent. In pre-clinical studies the intravenous version of neratinib resulted in higher exposure levels of neratinib in pre-clinical models.
PB357
PB357 is an orally administered agent that is an irreversible TKI that blocks signal transduction through the epidermal growth factor receptors, HER1, HER2, and HER4. PB357 is structurally similar to PB272. Pfizer completed single dose Phase I trials of PB357. The Company is evaluating PB357.
The Company competes with Genentech, GlaxoSmithKline, Roche, Boehringer Ingelheim, Takeda, Array Biopharma and Ambit Biosciences.
Advisors' Opinion:- [By Tom Rojas and Maria Armental var popups = dojo.query(".socialByline .popC"); ]
Puma Biotechnology Inc.(PBYI) said its investigational breast-cancer treatment showed a 33% improvement in disease-free survival over a placebo in a Phase 3 study. Share surged 271% to $218 premarket.
- [By Anna Prior]
Puma Biotechnology Inc.(PBYI) reported positive top-line data from the Phase II clinical trial of the biopharmaceutical company’s investigational drug PB272 for the neoadjuvant treatment of breast cancer.
- [By Ben Levisohn]
The Dow Jones Industrial Average and S&P 500 squeaked out new highs today, while the Nasdaq Composite and small caps dropped, following stronger-than-forecast manufacturing data out of China and a U.S. manufacturing survey that had to be corrected twice. Caterpillar (CAT) and Broadcom�(BRCM) gained, while Express Scripts (ESRX) and Puma Biotechnology (PBYI) tumbled.
Hot Tech Stocks To Buy Right Now: Qualys Inc (QLYS)
Qualys, Inc. (Qualys), incorporated on December 30, 1999, is a provider of clouds security and compliance solutions that enable organizations to identify security risks to their information technology (IT) infrastructures, help protect their IT systems and applications from cyber attacks and achieve compliance with internal policies and external regulations. The Company designed its QualysGuard Cloud Platform to transform the way organizations secure and protect their IT infrastructures and applications. The Company's cloud platform offers an integrated suite of solutions that automates the lifecycle of asset discovery, security assessments, and compliance management for an organization's IT infrastructure and assets, whether they reside inside the organization, on their network perimeter or in the cloud.
The Company provides its solutions through a software-as-a-service model, primarily with renewable annual subscriptions. These subscriptions require customers to pay a fee in order to access the Company's cloud solutions. The Company's QualysGuard Cloud Platform consists of a suite of IT security and compliance solutions that leverage the Company's shared and extensible core services and its scalable multi-tenant cloud infrastructure. The Company's suite of solutions provides security intelligence by automating the life cycle of IT asset discovery, security assessment and compliance management. The Company's cloud platform's infrastructure includes integrated services that deliver a automated and scalable scanning infrastructure capable of scanning IT systems and Web applications, inside and outside corporate firewalls. The Company also provides open application program interfaces (APIs), and other developer tools that allow third parties to embed its technology into their solutions and build applications on its cloud platform.
The Company's suite of solutions, which the Company refers to as the QualysGuard Cloud Suite, includes Vulnerability Management, Web Application Sca! nning, Malware Detection Service, Policy Compliance, PCI Compliance and Qualys SECURE Seal. The Company's customers can subscribe to one or more of the Company's security and compliance solutions based on their initial needs and expand their subscriptions over time to new areas within their organization or to additional QualysGuard solutions. The Company offers two editions of its QualysGuard Cloud Suite, the Enterprise edition for large and medium-sized enterprises and the Express edition for small and medium-sized businesses.
QualysGuard Vulnerability Management (QualysGuard VM), is a solution that automates network auditing and vulnerability management across an organization, including network discovery and mapping, asset management, vulnerability reporting, and remediation tracking. QualysGuard Policy Compliance (QualysGuard PC) allows customers to analyze and collect configuration and access control information from their networked devices and Web applications and automatically maps this information to internal policies and external regulations in order to document compliance.
QualysGuard PCI Compliance (QualysGuard PCI) provides organizations that store cardholder data a automated solution to verify and document compliance with PCI DSS. QualysGuard Web Application Scanning (QualysGuard WAS) uses the scalability of its cloud platform to allow customers to discover, catalog and scan a large number of Web applications. QualysGuard Malware Detection Service (QualysGuard MDS) provides organizations with the ability to scan identify and remove malware infections from their Websites. QualysGuard Web Application Firewall (QualysGuard WAF) delivers enterprise-grade Web application security without associated with appliance-based Web application firewall solutions. QualysGuard SECURE Seal helps organizations demonstrate to their online customers that they maintain a proactive security program.
Core Services include asset tagging and management, reporting and dashboards! , questio! nnaires and collaboration, remediation and workflow, big data correlation and analytics engine, and alerts and notifications. The Company�� infrastructure layer, which it refer to as its Infrastructure, includes the data, data processing capabilities, software and hardware infrastructure and infrastructure management capabilities that provide the foundation for its cloud platform and allow the Company to automatically scale its Infrastructure and Core Services to scan millions of Internet protocols (IPs).
The Company competes with Hewlett-Packard Company, Imperva, Inc., International Business Machines Corporation, McAfee, Inc., Symantec Corporation, Barracuda Networks, Inc., BeyondTrust Software, Inc., Lumension Security, Inc., nCircle Network Security, Inc., NetIQ Corporation, Rapid7 LLC, Tenable Network Security, Inc. and Trustwave Holdings, Inc.
Advisors' Opinion:- [By Jake L'Ecuyer]
Equities Trading UP
Qualys (NASDAQ: QLYS) shares shot up 8.24 percent to $20.68 after the company reported upbeat quarterly results.Shares of Office Depot (NYSE: ODP) got a boost, shooting up 15.95 percent to $4.84 after the company reported upbeat quarterly earnings and announced its plans to close at least 400 stores in the US.
Hot Tech Stocks To Buy Right Now: InterMune Inc.(ITMN)
InterMune, Inc., a biopharmaceutical company, engages in the research, development, and commercialization of therapies in pulmonology and fibrotic diseases. In pulmonology, the company focuses on therapies for the treatment of idiopathic pulmonary fibrosis (IPF), a progressive and fatal lung disease. It markets pirfenidone, an orally active drug that inhibits the synthesis of TGF-beta under the Esbriet name in the European Union, as well as in a Phase III clinical trial in the United States. Pirfenidone is also approved for the treatment of IPF in Japan, where it is marketed by Shionogi & Co. Ltd. under the Pirespa trade name. The company?s research programs focus on the discovery of small-molecule therapeutics and biomarkers to treat and monitor serious pulmonary and fibrotic diseases. InterMune, Inc. was founded in 1998 and is headquartered in Brisbane, California.
Advisors' Opinion:- [By Sean Williams]
InterMune (NASDAQ: ITMN )
InterMune shares may have exploded higher by 30% over the past week, but there's certain to be a lot of nail-biting on the part of shareholders as we head into earnings season. The reason has been the slow acceptance of the company's idiopathic pulmonary fibrosis drug, Esbriet, based on its pricing in the EU. In previous quarters Esbriet sales have disappointed in a big way, but are expected to rise by 134% to nearly $13 million from last year, though losses are still anticipated to come in at $0.70 per share. Following its recent pop, Esbriet sales had better hit the mark, otherwise InterMune shareholders are probably going to be in for a long day.
No comments:
Post a Comment